AirSculpt Technologies Azioni (NASDAQ: AIRS)

Ultime notizie per AirSculpt Technologies (NASDAQ:AIRS) Azioni

AirSculpt Technologies

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies Inc

AirSwap - United States Dollar

Airship AI Holdings, Inc - Class A Common Stock

Airship AI Holdings Inc

Airspan Networks Holdings Inc

Airspan Networks Holdings Inc Warrants (01/11/2026)

Airspan Networks Holdings Inc Warrants - Class C (01/11/2026)

JP Morgan analyst Reginald Smith maintains Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Overweight and raises the price target from $47 to $56.

News

Price Target

Analyst Ratings

AFRM

JP Morgan Maintains Overweight on Affirm Holdings, Raises Price Target to $56

HC Wainwright &amp; Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBYI#NASDAQ">PBYI</a>) with a Buy and maintains $7 price target.

Reiteration

PBYI

HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

JP Morgan analyst Tien-Tsin Huang maintains Toast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) with a Neutral and raises the price target from $28 to $36.

TOST

JP Morgan Maintains Neutral on Toast, Raises Price Target to $36

Guidance

Fluor During Conference Call, Said Company 'Four Quarters Behind' Its Prior 2026 EBITDA Target

Keefe, Bruyette &amp; Woods analyst Sanjay Sakhrani maintains Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) with a Outperform and raises the price target from $380 to $400.

CPAY

Keefe, Bruyette & Woods Maintains Outperform on Corpay, Raises Price Target to $400

JP Morgan analyst Rahul Krotthapalli maintains Planet Fitness (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) with a Overweight and raises the price target from $80 to $90.

PLNT

JP Morgan Maintains Overweight on Planet Fitness, Raises Price Target to $90

WIIM

RIGL

Rigel Pharmaceuticals shares are trading higher after the company reported better-than-expected Q3 financial results.

JP Morgan analyst Doug Anmuth maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Neutral and raises the price target from $121 to $142.

ABNB

JP Morgan Maintains Neutral on Airbnb, Raises Price Target to $142

HC Wainwright &amp; Co. analyst Robert Burns reiterates Repare Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>) with a Buy and maintains $10 price target.

RPTX

HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $10 Price Target

<a href="https://www.bnnbloomberg.ca/business/company-news/2024/11/08/boeing-ceo-says-furloughed-workers-will-be-paid-for-lost-time/#:~:text=%E2%80%9CAs%20we%20navigated%20through%20the,first%20weeks%20of%20his%20tenure.">https://www.bnnbloomberg.ca/business/company-news/2024/11/08/boeing-ceo-says-furloughed-workers-will-be-paid-for-lost-time/#:~:text=%E2%80%9CAs%20we%20navigated%20through%20the,first%20weeks%20of%20his%20tenure.</a>
Boeing Co. Chief Executive Officer Kelly Ortberg moved to patch up relations with workers after a bruising seven-week strike, saying the company would pay employees who were put on mandatory leave during the disruption at its Seattle manufacturing hub.
"As we navigated through the work stoppage, we asked many of you to take a furlough to support our cash conservation efforts," Ortberg said in a memo to staff. "We want to acknowledge your support by returning your lost pay."
Ortberg made the temporary cuts as cash concerns mounted in the first weeks of his tenure. The strike by Seattle-area factory workers paralyzed plane output already suppressed by a months-long crisis tied to quality issues in its planemaking operations.&nbsp;
The gesture of goodwill to furloughed staff signals the CEO's attention has shifted toward mending operations as he tries to get aircraft output back on track. The walkout is now settled, with union members receiving 38% wage increases and a $12,000 signing bonus. Ortberg has raised more than $20 billion to ease the company's cash crunch.&nbsp;
In the memo, Ortberg said the company will press ahead with job cuts to align with "our financial reality," a sign that the pain is far from over. Structural changes "are important to our competitiveness," he said. The company said last month that it would eliminate the equivalent of about 17,000 positions to help preserve funds.
Boeing has initiated a range of cost cuts as it grapples with dwindling reserves and low output, including hiring freezes and cutbacks in corporate travel. The company has said it expects to continue burning cash in the first half of next year as it works to restore output.&nbsp;
Ortberg has also said he plans to review non-core assets with a view to refocusing on the commercial planemaking business.&nbsp;

Management

Reported Earlier, "Boeing CEO Says Furloughed Workers Will Be Paid for Lost Time" - BNN Bloomberg

Crypto analyst Benjamin Cowen suggests that Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dominance might continue climbing, even as it hits his long-standing 60% target, following the <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41820253/fed-cuts-interest-rates-to-lowest-since-february-2023-sticks-to-data-driven-path">Fed's recent 25 basis point interest rate cut</a>.
What Happened: In an update on his YouTube <a href="https://youtu.be/NPu6mfY_Pz8?si=35Qnt5mVElqCe9nx">channel</a>, Cowen analyzed the Federal Reserve's <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41820253/fed-cuts-interest-rates-to-lowest-since-february-2023-sticks-to-data-driven-path">decision to reduce rates</a> to lowest level since February 2023 and maintain quantitative tightening by continuing to reduce its holdings in Treasury securities and mortgage-backed securities.
He highlighted that Bitcoin's dominance has typically peaked (60%) only after quantitative easing (QE) starts. This time, he sees two possible scenarios: Bitcoin dominance could begin a topping process, or it might overshoot its peak before settling back.
He also emphasized monitoring Ethereum's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) performance against Bitcoin, as it plays a key role in dominance trends. Cowen recommended dollar-cost averaging in altcoins as the market heads into the post-halving phase.
Quoting the Federal Reserve&#8217;s press release, Cowen highlighted that the committee plans to "continue reducing its Holdings of Treasury Securities and agency debt and agency mortgage-backed Securities." He stressed the potential influence of this decision on the crypto market.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41841793/bitcoin-ethereum-solana-rally-does-not-mean-all-cryptocurrencies-will-moon-10x-research">Bitcoin, Ethereum, Solana Rally Does Not Mean All Cryptocurrencies Will Moon: 10x Research</a>
Why It Matters: Despite his cautious outlook, Cowen anticipates Bitcoin will adhere to its cyclical behaviour. He warned, however, that a broader market correction could interrupt these patterns, impacting both Bitcoin and altcoins.
The Federal Reserve&#8217;s decision to lower interest rates has slowed the pace of rate cuts compared to September, when policymakers opted for a more substantial 0.5% cut to initiate the easing cycle.
A senior research strategist noted that that the Fed's gradual cuts toward a "neutral" 3% rate could be partly due to Trump's policies, including tariffs, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41824236/feds-interest-rate-cut-pace-expected-to-slow-economists-weigh-trumps-white-house-re">which may have a reflationary effect</a>.
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41807557/bitcoin-as-americas-gold-trumps-bitcoin-act-could-reshape-us-reserves-says-coinshares">Bitcoin As America&#8217;s Gold? How Trump&#8217;s Bitcoin Act Could Reshape US Reserves</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Federal Reserve Cuts Interest Rates—Bitcoin Dominance May Rise As A Result

ALVR

AlloVir shares are trading lower. The company announced that it has entered into a definitive merger agreement to combine with Kalaris Therapeutics.

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains CNA Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>) with a Market Perform and raises the price target from $54 to $55.

Keefe, Bruyette & Woods Maintains Market Perform on CNA Financial, Raises Price Target to $55

JP Morgan analyst Rajat Gupta maintains CarGurus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) with a Overweight and raises the price target from $36 to $40.

CARG

JP Morgan Maintains Overweight on CarGurus, Raises Price Target to $40

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Revance Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) with a Neutral and maintains $6.6 price target.

RVNC

HC Wainwright & Co. Reiterates Neutral on Revance Therapeutics, Maintains $6.6 Price Target

JP Morgan analyst John Ivankoe maintains US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) with a Neutral and raises the price target from $68 to $69.

USFD

JP Morgan Maintains Neutral on US Foods Hldg, Raises Price Target to $69

Offerings

RRBI

Red River Bancshares Files $100M Mixed Securities Shelf

Global

iShares MSCI Poland Investable Market Index Fund ETF

EPOL

STLA

Stellantis/ Leapmotor Joint Venture Drops Plan To Add Second EV Model For Production In Poland; Considers Germany And Slovakia For A Potential Site To Its Second European EV Manufacturing Site

Needham analyst Ryan MacDonald maintains Docebo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCBO#NASDAQ">DCBO</a>) with a Buy and raises the price target from $50 to $60.

DCBO

Needham Maintains Buy on Docebo, Raises Price Target to $60

JP Morgan analyst Doug Anmuth maintains Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Neutral and lowers the price target from $38 to $35.

PINS

JP Morgan Maintains Neutral on Pinterest, Lowers Price Target to $35

Whit Mayo, an analyst from Leerink Partners, reiterated the Hold rating on Airsculpt Technologies, Inc. (AIRS – Research Report). The associated pr...

Hold Rating on Airsculpt Technologies Amidst Revenue Misses and Leadership Changes

AirSculpt started at neutral by BTIG, macroeconomic headwinds cited

Prior view was $180M-$190M, consensus $184.56M. The company is also maintaining its 2024 full year adjusted EBITDA outlook of $23M-$28M. Cites prel...

AirSculpt Technologies narrows  FY24 revenue view to $183M-$189M

AirSculpt revises annual revenue outlook

Analyst Whit Mayo of Leerink Partners reiterated a Hold rating on Airsculpt Technologies, Inc. (AIRS – Research Report), retaining the price target...

Airsculpt Technologies, Inc.: Hold Rating Maintained Amid Concerns Over Growth and Margin Pressure

InMode: A Deep Dive After Q3 Earnings

Reports Q3 revenue $42.54M, consensus $41.73M. "Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period ...

AirSculpt Technologies reports Q3 EPS (10c), consensus (5c)

Reaffirms FY24 adjusted EBITDA $23M-$28M; and Adjusted EBITDA to cash flow from operations conversion ratio of 50%. Expects 5 new centers to open i...

AirSculpt reaffirms FY24 revenue view $183M-$189M, consensus $185.23M

AirSculpt Technologies GAAP EPS of -$0.10, revenue of $42.5M

AirSculpt Technologies, Inc. (AIRS) Q3 2024 Earnings Call Transcript

AIRS

APYX

CUTR

INMD

Penny Stocks

Press Releases

AIRS Investors Have Opportunity to Join AirSculpt Technologies, Inc. Securities Fraud Investigation with the Schall Law Firm

AirSculpt Technologies, Inc. (AIRS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Legal

AirSculpt® Technologies, Inc. Announces Opening of Its New Center in Columbus, OH

AirSculpt® Technologies, Inc. Adds New Center In Deerfield, IL To Meet Chicago Market Demand

AirSculpt® Technologies, Inc. Announces Opening of Its New Center in Birmingham, MI

AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results

Earnings

AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results

Accolade

Agilon Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Biodesix

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare

Castle Biosciences

DocGo

Enhabit

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

Fulgent Genetics

InnovAge Holding

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

23andMe Holding

ModivCare

National Research Corporation - Common Stock

National Research

Nutex Health

OPKO Health

Performant Financial Corporation - Common Stock

Performant Finl

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Pennant Gr

SBC Medical Group Holdings Incorporated - Common Stock

Comments

AirSculpt Technologies

Notizie

Ultime notizie per AirSculpt Technologies (NASDAQ:AIRS) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO